BMRNCommon stockNASDAQ
BMRN Common stock
This is the ticker-level security page. The issuer is BioMarin Pharmaceutical.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$3.1B
Net income TTM
$520.4M
Total assets
$7.6B
Total debt
Not available
Total equity
$6.1B
Profit margin
16.8%
ROE
8.6%
ROA
6.8%
Latest issuer financial snapshot: 2024-12-31